Cystic Fibrosis of Pancreas
2
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Ms1819sd
Related Conditions
Often studied with 12 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Ms1819sd1
Active Sponsors
- AzurRx SAS1
- Copenhagen University Hospital, Denmark1
- Herlev and Gentofte Hospital1
Top Investigators
Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen
CF Centre Copenhagen University Hospital Rigshospitalet
Viro-immunology Research Unit, Department of Infectious Diseases 8632, Copenhagen University Hospital Rigshospitalet, University of Copenhagen
CF Centre Copenhagen University Hospital Rigshospitalet
Department of Cardiology, Department of Biomedical Sciences, Herlev and Gentofte University Hospital, University of Copenhagen
Related Conditions
- Cystic Fibrosis Gastrointestinal Disease2
- Cystic Fibrosis2
- Cystic Fibrosis Pulmonary1
- Heart Failure1
- Heart Failure Systolic1